Thomas Hocker, MD
MOHS-Micrographic Surgery · Overland Park, KSNPI 1689841025
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by AbbVie at 33.9% of the total. Reporting peaked in 2023 at $246 and has fallen 90.0% since, to $24 in 2025.
Across 7 payments — averaging $48.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$116
- Lilly USA, LLC$106
- Acera Surgical, Inc.$25
- Hydrofera LLC$24
- Organogenesis Inc.$24
- Mimedx Group, Inc.$23
- plus $23 from 1 others
What the payments were for
- Food & beverage$342100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 1 | $116 |
| Lilly USA, LLC | 1 | $106 |
| Acera Surgical, Inc. | 1 | $25 |
| Hydrofera LLC | 1 | $24 |
| Organogenesis Inc. | 1 | $24 |
| Mimedx Group, Inc. | 1 | $23 |
| Convatec Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few mohs-micrographic surgery providers in Kansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 1,460 | $14,538 |
| Fluorouracil | 52 | $3,580 |
| Clobetasol Propionate | 22 | $663 |
| Triamcinolone Acetonide | 30 | $260 |
| Doxycycline Monohydrate | 20 | $228 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 70 | $223 |
| Ketoconazole | 17 | $222 |
| Cefadroxil | 15 | $89 |
| Levofloxacin | 13 | $63 |
| Cephalexin | 12 | $45 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Overland Park
- Timothy ParkerOverland Park$17
- Joseph GadziaTopeka$28K
- Mark FleischmanLeawood$23K
- Majdy AlbahharManhattan$10K
- Matthew ShafferSalina$8K
- Kevin BroughWichita$8K
- James GriffithLeawood$5K
- Shawn SabinLeawood$4K
- Glenn GoldsteinLeawood$2K
- Elizabeth SpenceriLeawood$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.